BREAST CANCER
Risk Factors:- Age >50
- Family History
- LCIS or atypical hyperplasia
- Dense breast tissue
- BRCA mutation
- Invasive
- Ductal
- Lobular
- Mucinous
- Tubular
- Non-invasive
- DCIS (does not metastasize)
- Mammogram is a SCREENING TOOL
- FNA
- Excisional Bx
- Core BxSterotactic BX
- Known BRCA mutation
- First degree relative with BRCA mutation
- 20% risk based on validated model (BRACA-Pro)
- Other familial syndrome
- Cowden, Li-Fraummeni, HNPCC
- Hx of chest wall RT btwn 10-30yr of age
- e.g. Hodgkins disease
- Surgical Treatment
- Mastectomy
- Breast conversation
- Lumpectomy with XRT
- ER, PR, Her 2 nu status
- Adjunct therapy to minimize risk of recurrence
- Tamoxifen
- Aromatase inhibitor (Irimidex)
- Herceptin
T1a: 95% 96%
T1b: 90% 93%
T1c: 80% 86.5%
T2aN0: 70% 80%
T2bN1: 60% 73%
T3aN0: 70% 80%
T3bN1: 40% 60%
TXNXM1: <5% style="font-weight: bold;" size="4">Tamoxifen:
5 yrs duration (newer data to support 10)
Decreases recurrence risk by 37-54%
Increases overall survival by 11-34%
Monitor for development of endometrial cancer
0 comments:
Post a Comment